Cencora, Inc.

COR NYSE CIK: 0001140859

Company Information

Industry Wholesale-Drugs, Proprietaries & Druggists' Sundries
SIC Code 5122
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address 1 WEST FIRST AVENUE, CONSHOHOCKEN, PA, 19428
Mailing Address 1 WEST FIRST AVENUE, CONSHOHOCKEN, PA, 19428
Phone 610-727-7000
Fiscal Year End 0930
EIN 233079390

Financial Overview

FY2025 FY

$262.17B
Revenue
$76.59B
Total Assets
$645.94M
Stockholders' Equity

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events February 13, 2026 View on SEC
424B2 Prospectus for shelf offering February 11, 2026 View on SEC
8-K Current report of material events February 11, 2026 View on SEC
8-K Current report of material events February 10, 2026 View on SEC
424B5 Prospectus supplement February 10, 2026 View on SEC
8-K Current report of material events February 4, 2026 View on SEC
10-Q Quarterly financial report February 4, 2026 View on SEC
3 Initial insider ownership report January 30, 2026 View on SEC
8-K Current report of material events January 22, 2026 View on SEC
DEF 14A Definitive proxy statement January 22, 2026 View on SEC

Annual Reports

10-K November 25, 2025
  • Achieved $260 billion in sales for fiscal year 2025, a 7% increase from the previous year.
  • Acquired Retina Consultants of America (RCA) on January 2, 2025, with $100 million in potential future payments.
View Analysis

Insider Trading

STRONG SELL 4 insiders 6 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 5122)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.